thioridazine has been researched along with Cyanosis in 1 studies
Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grollmuss, O | 1 |
| Sanchez-Delgado, E | 1 |
| Bader, H | 1 |
1 other study available for thioridazine and Cyanosis
| Article | Year |
|---|---|
Prevention of anaphylactoid shock in the rat by the calmodulin antagonist thioridazine.
Topics: Anaphylaxis; Animals; Blood Pressure; Calmodulin; Cyanosis; Heart Rate; Hyperemia; p-Methoxy-N-methy | 1989 |